Jefferson University Hospitals

Researchers from the Kimmel Cancer Center at Jefferson have been awarded a Susan G. Komen for the Cure Promise Grant of almost $6.7 million for five years for continued breast cancer research.

The project represents a multidisciplinary team of scientists from a consortium that also includes Walter Reed Army Medical Center and DecisionQ Inc. in Washington D.C., as well as the Windber Research Institute and MDR Global Inc. in Windber, Pa.

The principal investigator, Hallgeir Rui, MD, PhD, is a professor of Cancer Biology and Medical Oncology at Jefferson Medical College of Thomas Jefferson University. The co-principal investigator and leader of the clinical investigations associated with the project is Edith Mitchell, MD, medical oncologist and clinical professor of Medicine and Medical Oncology at Thomas Jefferson University and Associate Director of Diversity Programs for the Kimmel Cancer Center. The team will use the funds to investigate methods to optimize selection of patients for breast cancer treatment.

Read the full news release. You may also wish to visit the Jefferson Breast Care website.